St. Jude Resynchronization ICD Enrollment Trimmed By 150 Patients
This article was originally published in The Gray Sheet
Executive Summary
St. Jude continues to project that its Epic HF resynchronization ICD will not reach the U.S. market until early 2004, despite FDA permission to reduce the required sample size of the pivotal RHYTHM study